Lupin Pharmaceuticals Inc. has recalled 25,944 bottles of Lisinopril (30 mg) tablets, a medication used to treat high blood pressure and heart failure. The recall was initiated after a consumer reported finding a single 5 mg Lisinopril tablet mixed inside a bottle labeled as containing 100-count 30 mg tablets. This product mix-up means patients may unintentionally take a much lower dose of their medication than prescribed, which could lead to poorly controlled blood pressure.
Taking a 5 mg tablet instead of the prescribed 30 mg dose of Lisinopril may result in inadequate treatment of high blood pressure or heart failure, potentially leading to a sudden increase in blood pressure or worsening of heart conditions.
Contact healthcare provider and return product.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.